Delivery Order SPE2DE21D7020-SPE2D625F7KT9
- Not listed
- Boston Scientific Corp, a leading global medical technology company, was awarded a delivery order contract valued at $2,960.93 by the Defense Health Agency's Medical Supply Chain on May 30, 2025. The contract, designated as 4568394743 for a WOLVERINE MR 10MM device, represents a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of June 6, 2025. The place of performance is Boston Scientific's facilities in Marlborough, Massachusetts. This...
- Boston Scientific Corp, a Marlborough, Massachusetts-based global medical technology company, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on July 22, 2025, with an ultimate completion date of July 29, 2025. The contract, valued at $1,727.26, is structured as a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition in the federal marketplace. The award description references medical...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,303.44 by the Defense Health Agency's Medical Supply Chain program. This fixed-price contract with economic price adjustment, issued on July 28, 2025, is scheduled for completion by August 4, 2025. The award represents a non-set-aside competitive procurement, with performance occurring at Boston Scientific's Marlborough facility. As a...
- Boston Scientific Corp has been awarded a delivery order valued at $12,695.76 by the Defense Health Agency's Medical Supply Chain, an organization within the Department of Defense responsible for procuring medical devices and supplies for military healthcare systems. The contract, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, represents a fixed-price agreement with economic price adjustment provisions. The work will be performed at Boston Scientific's headquarters...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order with economic price adjustment valued at $4,860 by the Defense Health Agency's Medical Supply Chain division on September 2, 2025. The delivery order, with an ultimate completion date of September 9, 2025, represents a short-duration task order for specialized medical devices or equipment. As a major federal contractor, Boston Scientific supplies...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $25,908.90 for WOLVERINE MR 10MM medical devices. The contract, issued on August 13, 2025, with an ultimate completion date of August 20, 2025, is funded through the Defense Health Agency's Medical Supply Chain program within the Department of Defense. The award employs a fixed-price contract structure with economic price adjustment...
- Boston Scientific Corporation has been awarded a delivery order valued at $6,909.04 by the Defense Health Agency's Medical Supply Chain for the supply of a 3.5mm, 143cm, 10mm Wolverine mineral cut medical device component. The contract is a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of July 25, 2025. Performance will take place at Boston Scientific's facility in Marlborough, Massachusetts. No set-aside designation was applied to this...
- Boston Scientific Corp has been awarded a delivery order valued at $1,616.07 by the Defense Health Agency's Medical Supply Chain, a defense-focused federal healthcare procurement entity. The contract, issued on September 8, 2025, with an ultimate completion date of September 15, 2025, is structured as a fixed-price agreement with economic price adjustment provisions. Performance will occur at Boston Scientific's facility in Marlborough, Massachusetts. No set-aside designation was applied to this...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $8,795.18 by the Defense Health Agency's Medical Supply Chain on June 24, 2025. The contract employs fixed-price pricing with economic price adjustment terms and is scheduled for completion by July 1, 2025. The award is not set-aside and represents Boston Scientific's continued role as a prime contractor supplying advanced medical devices to federal...
- Boston Scientific Corp has been awarded a delivery order valued at $3,705.29 by the Defense Health Agency's Medical Supply Chain on July 18, 2025, with an ultimate completion date of July 25, 2025. This fixed-price contract with economic price adjustment authority represents a task order under a larger indefinite delivery vehicle and carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at the company's...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F7KT9Delivery Order
Boston Scientific Corp has been awarded a delivery order valued at $8,636.30 by the Defense Health Agency's Medical Supply Chain program on July 17, 2025, with an ultimate completion date of July 24, 2025. The contract, designated as a fixed-price delivery order with economic price adjustment, covers the supply of specialized medical equipment identified as "4568821263 ! BLN 3MM 143CM 10MM WOLVERINE MNRL CUT," which appears to be a specific medical device component or instrument within Boston Scientific's broad portfolio of cardiovascular and interventional medical technologies. Performance of this contract will take place at the company's Marlborough, Massachusetts facility. This award represents a non-set-aside competitive procurement, reflecting Boston Scientific's standing as a qualified federal contractor for advanced medical device supply. This delivery order falls within Boston Scientific's broader relationship with the Defense Health Agency and represents the company's ongoing role as a critical supplier of medical technologies to federal healthcare systems. Boston Scientific maintains significant indefinite delivery vehicles with the DHA and other federal agencies, including a single-award blanket purchase agreement valued at $750,000 through March 30, 2030, for radiation treatment devices. The company's federal contract portfolio demonstrates its comprehensive capability to provide specialized medical devices across multiple therapeutic areas, including cardiovascular interventions, neurostimulation systems, and diagnostic equipment to agencies such as the Department of Veterans Affairs and Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 7/17/25 |